University Politehnica of Bucharest   Report issue

Academic/Hospital Phase 2
Founded: Bucharest Romania (1818)

Organization Overview

First Clinical Trial
2018
NCT03656484
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

University Politechnica of Bucharest

Active Ingredients

Drugs in Phase 2 Trials (4)

hyaluronic acid (1 trial)

melatonin (1 trial)

metronidazole (flagyl) (1 trial)

tetracycline (tetrex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 2)

Periodontitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 4